Provided by Tiger Trade Technology Pte. Ltd.

Immix Biopharma, Inc.

13.66
+0.50003.80%
Post-market: 13.60-0.0600-0.44%19:30 EDT
Volume:1.51M
Turnover:20.41M
Market Cap:972.46M
PE:-15.76
High:13.76
Open:13.36
Low:13.12
Close:13.16
52wk High:13.76
52wk Low:1.94
Shares:71.19M
Float Shares:58.79M
Volume Ratio:1.00
T/O Rate:2.57%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.8667
EPS(LYR):-0.8930
ROE:-34.18%
ROA:-20.52%
PB:4.25
PE(LYR):-15.30

Loading ...

Aug 14, 2026

Beneficial Ownership Change

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Aug 13, 2026

Beneficial Ownership Change

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Aug 07, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 20, 2026

Major Issues Report

Form 8-K - Current report
Jun 05, 2026

Beneficial Ownership Change

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
May 29, 2026

Major Issues Report

Form 8-K - Current report
May 21, 2026

Major Issues Report

Form 8-K - Current report
May 21, 2026

[Supp]Public Prospectus

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
May 21, 2026

Major Issues Report

Form 8-K - Current report
May 15, 2026

Beneficial Ownership Change

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
May 07, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 05, 2026

Beneficial Ownership Change

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Mar 30, 2026

Major Issues Report

Form 8-K - Current report
Mar 27, 2026

[Rev.]Annual Report

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
Mar 25, 2026

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Mar 25, 2026

Major Issues Report

Form 8-K - Current report
Mar 25, 2026

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Jan 17, 2026

Correspondence

Form CORRESP - Correspondence
Dec 08, 2025

Major Issues Report

Form 8-K - Current report
Dec 08, 2025

[Supp]Public Prospectus

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses